These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3036940)

  • 1. Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study.
    Okuda H; Obata H; Nakanishi T; Furukawa R; Hashimoto E
    J Hepatol; 1987 Jun; 4(3):357-63. PubMed ID: 3036940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma abnormal prothrombin (des-gamma-carboxy prothrombin) as a marker of hepatocellular carcinoma.
    Fujiyama S; Morishita T; Hashiguchi O; Sato T
    Cancer; 1988 Apr; 61(8):1621-8. PubMed ID: 2450634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.
    Yamagata H; Nakanishi T; Furukawa M; Okuda H; Obata H
    J Gastroenterol Hepatol; 1995; 10(1):8-13. PubMed ID: 7620113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of des-gamma-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Ho CH; Lee SD; Chang HT; Wu JC; Tsai YT; Lo KJ
    Scand J Gastroenterol; 1989 Jan; 24(1):47-52. PubMed ID: 2467347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma.
    Ono M; Ohta H; Ohhira M; Sekiya C; Namiki M
    Am J Gastroenterol; 1990 Sep; 85(9):1149-54. PubMed ID: 1697141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.
    Weitz IC; Liebman HA
    Hepatology; 1993 Oct; 18(4):990-7. PubMed ID: 8406374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of plasma abnormal prothrombin (des-gamma-carboxy prothrombin) in hepatobiliary malignancies and other diseases.
    Nakao A; Suzuki Y; Isshiki K; Kimura Y; Takeda S; Kishimoto W; Nonami T; Harada A; Takagi H
    Am J Gastroenterol; 1991 Jan; 86(1):62-6. PubMed ID: 1702578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Murata K; Suzuki H; Okano H; Oyamada T; Yasuda Y; Sakamoto A
    Int J Oncol; 2009 Nov; 35(5):1005-14. PubMed ID: 19787254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas.
    Saitoh S; Ikeda K; Koida I; Tsubota A; Arase Y; Chayama K; Kumada H
    Cancer; 1994 Dec; 74(11):2918-23. PubMed ID: 7525036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of des-gamma-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma.
    Fujiyama S; Izuno K; Gohshi K; Shibata J; Sato T
    Dig Dis Sci; 1991 Dec; 36(12):1787-92. PubMed ID: 1721019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
    Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
    Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Murata K; Suzuki H; Okano H; Oyamada T; Yasuda Y; Sakamoto A
    Int J Oncol; 2010 Jan; 36(1):161-70. PubMed ID: 19956845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Watanabe K; Magario N; Yokoo T; Naraki T
    Cancer; 1999 Feb; 85(4):812-8. PubMed ID: 10091758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of des-gamma-carboxyprothrombin using staphylocoagulase. Application to the diagnosis of cellular hepatocarcinoma.
    Soulier JP; Gozin D; Lefrère JJ
    Haematologia (Budap); 1986; 19(1):3-12. PubMed ID: 2424813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma.
    Ohhira M; Ohtake T; Saito H; Ikuta K; Tanaka K; Tanabe H; Kawashima T; Fujimoto Y; Naraki T; Ono M; Kohgo Y
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):67S-70S. PubMed ID: 10235282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma.
    Mita Y; Aoyagi Y; Yanagi M; Suda T; Suzuki Y; Asakura H
    Cancer; 1998 May; 82(9):1643-8. PubMed ID: 9576283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: comparison of the conventional enzyme immunoassay and two modified methods.
    Nomura F; Ishijima M; Horikoshi A; Nakai T; Ohnishi K
    Am J Gastroenterol; 1996 Jul; 91(7):1380-3. PubMed ID: 8677999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of immunoreactive prothrombin precursor and vitamin-K-dependent gamma-carboxylation in human hepatocellular carcinoma tissues: decreased carboxylation of prothrombin precursor as a cause of des-gamma-carboxyprothrombin synthesis.
    Ono M; Ohta H; Ohhira M; Sekiya C; Namiki M
    Tumour Biol; 1990; 11(6):319-26. PubMed ID: 2173855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of the assay of des-gamma-carboxy prothrombin in the detection of small hepatocellular carcinoma.
    Chan CY; Lee SD; Wu JC; Lin HC; Huang YS; Lo GH; Lee FY; Tsai YT; Lo KJ
    J Hepatol; 1991 Jul; 13(1):21-4. PubMed ID: 1717542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.